 Shares of CureVac CVAC, -0.28 were up 0.6 in premarket trading on Monday after the company and GlaxoSmithKline GSK, 0.89 said they signed an agreement with the German government for pandemic preparedness that includes mRNA vaccines. As part of the agreement, Germany has access to CureVacs mRNA manufacturing until 2029. 